You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

spartalizumab

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Oesophageal Adenocarcinoma, Gastric Adenocarcinoma Trial in France (Capmatinib, Spartalizumab)

Suspended
  • Oesophageal Adenocarcinoma
  • Gastric Adenocarcinoma
  • Besançon, France
  • +6 more
Feb 1, 2023

Carcinoma, Renal Cell Trial in New York (Spartalizumab, Canakinumab)

Recruiting
  • Carcinoma, Renal Cell
  • New York, New York
    Columbia University Medical Center
May 6, 2022

Head and Neck Squamous Cell Carcinoma Trial in Taipei (Ribociclib, Spartalizumab)

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Taipei, Taiwan
    National Taiwan University Hospital
Apr 19, 2022

Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID

Active, not recruiting
  • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2022

MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

Active, not recruiting
  • MSI-H Colorectal Cancer
  • +30 more
  • Spartalizumab
  • Badalona, Barcelona, Spain
  • +9 more
Oct 24, 2022

NSCLC Trial in Worldwide (Capmatinib, Spartalizumab, Docetaxel)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Fayetteville, Arkansas
  • +7 more
Jan 21, 2022

Non-small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, Esophageal SCC Trial in Worldwide (TNO155, Spartalizumab,

Recruiting
  • Non-small Cell Lung Carcinoma
  • +4 more
  • Boston, Massachusetts
  • +8 more
Mar 18, 2022

MDS, Leukemia, Myelomonocytic, Chronic Trial (decitabine, Spartalizumab, Sabatolimab)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Leukemia, Myelomonocytic, Chronic
  • (no location specified)
Aug 5, 2022

Primary Myelofibrosis, Myelofibrosis, PMF Trial (MBG453, NIS793, Spartalizumab)

Withdrawn
  • Primary Myelofibrosis
  • +4 more
  • (no location specified)
Mar 2, 2021

BRAF V600 Colorectal Cancer Trial in Worldwide (Dabrafenib, LTT462, Trametinib)

Recruiting
  • BRAF V600 Colorectal Cancer
  • Los Angeles, California
  • +17 more
Jun 7, 2022

Nasopharyngeal Carcinoma Trial in Worldwide (Spartalizumab, Investigator choice of chemo)

Completed
Has Results
  • Nasopharyngeal Carcinoma
  • Spartalizumab
  • Investigator choice of chemotherapy
  • Marietta, Georgia
  • +17 more
Jan 17, 2022